Corrigendum: Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3

Yinteng Wu; Bo Zhang; Juan Nong; Raquel Alarcon Rodriguez; Wenliang Guo; Ying Liu; Shijian Zhao; Ruqiong Wei

doi:10.3389/fgene.2023.1204421

Corrigendum: Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3

Front Genet. 2023 May 23:14:1204421. doi: 10.3389/fgene.2023.1204421. eCollection 2023.

Authors

Yinteng Wu¹, Bo Zhang², Juan Nong³, Raquel Alarcon Rodriguez⁴, Wenliang Guo⁵, Ying Liu⁶, Shijian Zhao⁷, Ruqiong Wei⁶

Affiliations

¹ Department of Orthopedic and Trauma Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
² Department of Trauma Hand Surgery, The Second Nanning People's Hospital, Nanning, Guangxi, China.
³ Department of Joint Surgery, The Second Nanning People's Hospital, Nanning, Guangxi, China.
⁴ Faculty of Health Sciences, University of Almerìa, Almeria, Spain.
⁵ Department of Rehabilitation Medicine, Guigang City People's Hospital, Guigang, China.
⁶ Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
⁷ Department of Cardiology, The Affiliated Cardiovascular Hospital of Kunming Medical University (Fuwai Yunnan Cardiovascular Hospital), Kunming, Yunnan, China.

Abstract

[This corrects the article DOI: 10.3389/fgene.2023.1045061.].

Keywords: collagen; epithelial-mesenchymal transition (EMT); immunotherapy; pan-cancer; prolyl 4-hydroxylase subunit alpha 3 (P4HA3); the tumor microenvironment (TME).

Publication types

Published Erratum